Arthur Lahr | Thought Leader | Pharma’s Almanac

Community

Arthur Lahr

Chief Executive Officer and co-founder, Avidicure

Arthur Lahr is Chief Executive Officer and co-founder of Avidicure. His previous biotech roles included CEO of Kiadis Pharma, Chief Strategy Officer at Crucell, and others.

1 Contributions1 / 1

Antibodies

Co-Founders of Biotech Avidicure Talk New Antibody Modality, Starting from Scratch, and $50M Launch

Robert Friesen, Ph.D.; Govert Schouten; Arthur Lahr

Avidicure

PAO-08-25-CL-10Aug 22, 2025

1 / 1

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us Nice Insight That's Nice

Reach Our Team

My Account

Subscribe for the newsletter

Subscribe for the Newsletter

Mobile Navigation

Community

Antibodies

Co-Founders of Biotech Avidicure Talk New Antibody Modality, Starting from Scratch, and $50M Launch

Robert Friesen, Ph.D.; Govert Schouten; Arthur Lahr

Avidicure

Antibodies

Co-Founders of Biotech Avidicure Talk New Antibody Modality, Starting from Scratch, and $50M Launch

Robert Friesen, Ph.D.; Govert Schouten; Arthur Lahr

Avidicure